NSC |
Compound |
Enrichment |
Correlation |
NSC 661115 |
Physalin F |
0.0130238833303634 |
-0.18121887 |
NSC 672210 |
Null |
0.0130238833303634 |
0.032370976 |
NSC 683061 |
Null |
0.0130238833303634 |
0.081485544 |
NSC 699934 |
Null |
0.0130238833303634 |
-0.25017146 |
NSC 701022 |
Null |
0.0130238833303634 |
0.12482531 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0130238833303634 |
0.26443877 |
NSC 711077 |
Null |
0.0130238833303634 |
0.085133847 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0130238833303634 |
-0.012446638 |
NSC 729166 |
N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide |
0.0130238833303634 |
-0.028324075 |
NSC 741425 |
3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide |
0.0130238833303634 |
0.031976796 |